William Blair Has Optimistic Outlook of InnovAge Q3 Earnings

InnovAge Holding Corp. (NASDAQ:INNV - Free Report) - William Blair boosted their Q3 2025 EPS estimates for shares of InnovAge in a report released on Tuesday, February 4th. William Blair analyst J. Haase now expects that the company will post earnings of ($0.01) per share for the quarter, up from their prior forecast of ($0.02). The consensus estimate for InnovAge's current full-year earnings is ($0.09) per share. William Blair also issued estimates for InnovAge's FY2025 earnings at ($0.15) EPS and FY2026 earnings at $0.08 EPS.

InnovAge (NASDAQ:INNV - Get Free Report) last posted its earnings results on Tuesday, February 4th. The company reported ($0.10) EPS for the quarter. InnovAge had a negative return on equity of 9.45% and a negative net margin of 3.19%.

Separately, JPMorgan Chase & Co. reiterated an "underweight" rating and set a $5.00 target price on shares of InnovAge in a research note on Tuesday, December 17th.

InnovAge Stock Performance

Shares of NASDAQ INNV traded up $0.04 during trading hours on Friday, hitting $3.38. 27,275 shares of the stock were exchanged, compared to its average volume of 57,791. The firm has a market capitalization of $456.45 million, a P/E ratio of -17.76 and a beta of 0.37. InnovAge has a one year low of $3.12 and a one year high of $6.69. The company's 50 day moving average is $3.95 and its 200 day moving average is $5.16. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.16 and a quick ratio of 1.21.

Hedge Funds Weigh In On InnovAge

A number of hedge funds have recently made changes to their positions in INNV. Geode Capital Management LLC increased its position in shares of InnovAge by 5.5% during the 3rd quarter. Geode Capital Management LLC now owns 527,955 shares of the company's stock worth $3,168,000 after purchasing an additional 27,304 shares in the last quarter. Barclays PLC increased its position in shares of InnovAge by 289.0% during the 3rd quarter. Barclays PLC now owns 25,614 shares of the company's stock worth $154,000 after purchasing an additional 19,029 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of InnovAge by 191.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 24,687 shares of the company's stock worth $148,000 after purchasing an additional 16,217 shares in the last quarter. SG Americas Securities LLC bought a new stake in InnovAge during the 4th quarter worth about $43,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in InnovAge by 3.9% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 165,531 shares of the company's stock worth $993,000 after acquiring an additional 6,153 shares during the last quarter. Institutional investors and hedge funds own 12.26% of the company's stock.

About InnovAge

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.